An Amplified Luminescent Proximity Homogeneous Assay-Implemented CRISPR/Cas13a System for Noncoding RNA Detection
The Alpha-CRISPR RNA detection system developed in this study integrates AlphaLISA technology with the CRISPR-Cas13a system, achieving significantly enhanced detection sensitivity, demonstrating substantial application potential in fundamental medical research and clinical diagnostics.